$15.8B
$546,000
0.01% of portfolio
10,900
Q3 2024
Reduced 88.92%
$89.8B
$274,000
0.01% of portfolio
720
Q3 2024
Added 4.2%
$12.4B
$560,000
0.01% of portfolio
7,970
Q3 2024
Added 30.23%
$518M
$772,000
0.01% of portfolio
28,490
Q2 2021
Added 7.15%
$11.2B
$405,000
0.01% of portfolio
2,500
Q3 2024
New
$19.6B
$503,000
0.01% of portfolio
6,115
Q3 2024
Reduced 0.24%
$98.9B
$728,000
0.01% of portfolio
10,100
Q4 2022
New
$107B
$469,000
0.01% of portfolio
3,088
Q2 2024
Reduced 0.99%
$1.91B
$640,000
0.01% of portfolio
14,700
Q4 2021
Reduced 21.39%
$106B
$446,000
0.01% of portfolio
2,000
Q3 2024
Added 100.0%
$194B
$497,000
0.01% of portfolio
1,272
Q3 2024
Reduced 3.78%
$19.5B
$485,000
0.01% of portfolio
1,080
Q3 2024
Added 100.0%
$19.4B
$282,000
0.01% of portfolio
5,625
Q3 2024
Reduced 35.71%
$145B
$671,000
0.01% of portfolio
3,324
Q3 2024
Reduced 5.43%
$11.9B
$331,000
0.01% of portfolio
2,740
Q3 2024
Reduced 1.26%
$25.9B
$366,000
0.01% of portfolio
3,500
Q3 2023
Reduced 0.14%
$155B
$312,000
0.01% of portfolio
1,154
Q3 2024
Added 0.61%
$11.1B
$699,000
0.01% of portfolio
4,030
Q3 2024
Reduced 0.25%
$3.27B
$699,000
0.01% of portfolio
30,000
Q4 2023
Reduced 25.0%
$0
$401,000
0.01% of portfolio
9,621
Q2 2024
New
$32.4B
$280,000
0.01% of portfolio
3,497
Q3 2024
New
$191B
$659,000
0.01% of portfolio
5,437
Q3 2024
Added 7.75%
$462M
$501,000
0.01% of portfolio
85,500
Q2 2024
Reduced 88.12%
$575M
$736,000
0.01% of portfolio
23,000
Q1 2024
Added 17.95%
$58.1B
$294,000
0.01% of portfolio
3,664
Q3 2024
Reduced 0.19%
$0
$0
0.0% of portfolio
545,991
Q3 2024
Reduced 0.24%
Net Lease Office Properties
-
$0
0.0% of portfolio
-
Q1 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
New
$65.2B
$246,000
0.0% of portfolio
2,202
Q3 2024
New
Ptc Therapeutics Inc (Ptct)
-
$0
0.0% of portfolio
-
Q2 2022
New
Patrick Industries Inc (Patk)
-
$0
0.0% of portfolio
-
Q4 2022
New
Mirum Pharmaceuticals (Mirm)
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 20.0%
Lumentum Holdings (Lite) 10.
-
$0
0.0% of portfolio
-
Q4 2022
Reduced 40.0%
Live Nation (Lyv) 9.4469 Conv
-
$0
0.0% of portfolio
-
Q4 2022
New
Greenbrier Cos Inc (Gbx) 18.
-
$0
0.0% of portfolio
-
Q2 2022
New
Exact Sciences (Exas) 8.2076
-
$0
0.0% of portfolio
-
Q2 2020
Reduced 25.0%
Array Technologies Inc (Arry)
-
$0
0.0% of portfolio
-
Q1 2024
Added 100.0%
Apellis Pharmaceuticals Inc (A
-
$0
0.0% of portfolio
-
Q3 2020
New
Royal Caribbean Cruises (Rcl)
-
$0
0.0% of portfolio
-
Q3 2023
New
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 4.88%
$462B
$218,000
0.0% of portfolio
1,281
Q3 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
New
Biomarin Pharmaceutical (Bmrn)
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 85.71%
Stride Inc (Lrn) 18.9109 Con
-
$0
0.0% of portfolio
-
Q3 2021
New
-
$0
0.0% of portfolio
-
Q3 2024
Added 0.3%
-
$0
0.0% of portfolio
-
Q4 2023
New
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 2.18%
-
$0
0.0% of portfolio
-
Q3 2024
Added 28.73%
$1.41B
$229,000
0.0% of portfolio
13,575
Q3 2024
Reduced 1.77%
-
$0
0.0% of portfolio
-
Q2 2023
New